Clinically, this autosomal dominant disorder was characterized by dementia, disinhibition, bradykinesia, rigidity, and superior gaze palsy, and pathologically by abundant, widespread hyperphosphorylated fibrillary tau deposits without Aβ pathology. The gene discussed is MAPT; the disease is dementia.